SCHEMBL626172

SCHEMBL626172

Cc1cncc(-c2cn3nc(NC4CCN(S(C)(=O)=O)CC4)sc3n2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.38
CCNE1 P24864 12/20 0.37
CDK2 P24941 12/20 0.37
CCNB2 O95067 3/20 0.37
CCNE2 O96020 3/20 0.37
CDK1 P06493 3/20 0.37
CCNB1 P14635 3/20 0.37
CDK5 Q00535 3/20 0.37
CDK5R1 Q15078 3/20 0.37
CCNB3 Q8WWL7 3/20 0.37
IDO1 P14902 2/20 0.37
IKBKB O14920 1/20 0.37
CCND1 P24385 3/20 0.36
CDK6 Q00534 3/20 0.36
CCNT1 O60563 2/20 0.36
CDK4 P11802 2/20 0.36
CDK9 P50750 2/20 0.36
IRAK1 P51617 1/20 0.36
MAPT P10636 1/20 0.35
FYN P06241 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL624431 0.88 FYN (0.48) DYRK1ACCNE1CDK2CCNB2CCNE2
SCHEMBL626165 0.87 IDO1 (0.47) CCNE1CDK2CCNB2CCNE2CDK1
SCHEMBL626187 0.87 JAK3 (0.38) DYRK1ACCNE1CDK2CCNB2CCNE2
SCHEMBL626171 0.81 FYN (0.54) FYNKCNH2
SCHEMBL626207 0.81 MAP3K12 (0.46) CCNE1CDK2CDK1CCNB1IDO1
SCHEMBL623928 0.80 FYN (0.49) DYRK1ACDK2CDK1CDK5IKBKB
SCHEMBL627168 0.78 CCNE1 (0.39) CCNE1CDK2CCNB2CCNE2CDK1
SCHEMBL626704 0.77 CCNE1 (0.43) CCNE1CDK2CCNB2CCNE2CDK1
SCHEMBL624394 0.76 CCNE1 (0.41) CCNE1CDK2CCNB2CCNE2CDK1
SCHEMBL625477 0.75 FYN (0.50) MAPTFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed